Several analysts have recently updated their ratings and price targets for Cardinal Health (NYSE: CAH):
- 10/30/2026 – Cardinal Health had its price target raised by Morgan Stanley from $265.00 to $286.00. They now have an “overweight” rating on the stock.
- 10/25/2026 – Cardinal Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
- 10/20/2026 – Cardinal Health had its price target raised by Mizuho from $250.00 to $280.00. They now have an “outperform” rating on the stock.
- 10/17/2026 – Cardinal Health was downgraded by Wall Street Zen from “strong-buy” to “buy”.
- 10/16/2026 – Cardinal Health had its price target raised by UBS Group from $280.00 to $295.00. They now have a “buy” rating on the stock.
- 10/8/2026 – Cardinal Health was upgraded by Weiss Ratings from “buy (b)” to “buy (b+)”.
- 9/27/2026 – Cardinal Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
- 9/19/2026 – Cardinal Health was downgraded by Wall Street Zen from “strong-buy” to “buy”.
Cardinal Health Trading Up 1.3%
NYSE CAH opened at $256.30 on Wednesday. The company has a fifty day simple moving average of $238.67 and a 200 day simple moving average of $222.72. Cardinal Health, Inc. has a 12-month low of $180.45 and a 12-month high of $259.84. The company has a market cap of $59.35 billion, a P/E ratio of 35.45, a PEG ratio of 1.53 and a beta of 0.53.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The firm had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. During the same period in the prior year, the business posted $2.08 earnings per share. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 12.55 EPS for the current year.
Cardinal Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st were paid a $0.5158 dividend. The ex-dividend date was Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. Cardinal Health’s payout ratio is presently 28.49%.
Insider Activity at Cardinal Health
In related news, CEO Stephen M. Mason sold 35,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the sale, the chief executive officer owned 18,061 shares of the company’s stock, valued at approximately $4,269,620.40. This represents a 65.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Deborah Weitzman sold 7,354 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the transaction, the chief executive officer owned 77,901 shares of the company’s stock, valued at $18,341,790.45. This trade represents a 8.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 210,271 shares of company stock worth $49,626,657 in the last three months. Corporate insiders own 0.12% of the company’s stock.
Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.
Read More
- Five stocks we like better than Cardinal Health
- High Voltage Returns: Talen Energy Powers the Data Center Rush
- 3 Dividend Increases Above 10%, But Which Offers the Most Income?
- Meta’s $100 Billion AI Financing Plan Has a Catch for Existing Shareholders
- Tower Semiconductor’s Earnings Are Soaring—So Why Is Its Stock Down More Than 50%?
Receive News & Ratings for Cardinal Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.
